Study Design & Protocol Development
- Observational studies (retrospective and prospective)
- Pragmatic trials
- Registry development and management
- Patient-centered outcomes research (PCOR)
Turning real world data into actionable insights
Real World Evidence (RWE) is an essential driver of innovation in modern healthcare. It complements traditional clinical trials and provides critical insights that inform regulatory decisions, support health economics and outcomes research (HEOR), and identify treatment gaps and unmet needs.
Our RWE Unit combines deep therapeutic expertise with advanced data analytics to generate credible, decision-ready evidence. These insights help shape regulatory strategies, strengthen market access, support precision medicine, and enhance patient-centered care.
From early-stage planning to post-marketing analysis, we equip you with the tools to drive value across the product lifecycle.
Our core RWE capabilities
Data Source Identification & Integration
- Identification of high-quality, fit-for-purpose real-world data sources
- Integration of diverse datasets to enable comprehensive, longitudinal patient-level analyses
- Evaluation of data quality, relevance, and regulatory acceptability
Data Analysis & Biostatistics
- Advanced statistical modeling
- Comparative effectiveness and safety analyses
- Propensity score matching, causal inference techniques
Regulatory Evidence Generation
- RWE to support label expansion or post-marketing requirements
- EMA guidance-aligned study conduct
Manuscript and Report Writing
- Scientific writing for peer-reviewed publication
- White papers, health policy briefs, and stakeholder summaries
Build a smarter, evidence-based future
Whether you’re exploring new indications, seeking payer acceptance, or advancing patient-centric innovation—our RWE experts will help you move forward with purpose.